433938-51-3 Usage
Properties
Chemical compound
Derivative of azetidinecarboxamide
Contains hydroxyacetyl, chlorine, trifluoromethoxy, imino, and pyridinylmethoxyamino groups
Specific content
1-[(2R)-[3-chloro-5-(trifluoromethoxy)phenyl]hydroxyacetyl]-N-[[4-[imino[(3-pyridinylmethoxy)amino]methyl]phenyl]methyl]-, (2S) configuration
Hydroxyacetyl group attached to phenyl ring
Chlorine and trifluoromethoxy groups in phenyl ring
Imino group linked to phenylmethyl group
Pyridinylmethoxyamino group linked to phenylmethyl group
Explanation
The compound has a complex structure with various functional groups attached to the phenyl ring
The presence of these groups indicates potential pharmacological properties and suggests applications in medicinal chemistry or drug development
Further research is needed to determine the specific biological activities and potential benefits of 2-Azetidinecarboxamide,
1-[(2R)-[3-chloro-5-(trifluoromethoxy)phenyl]hydroxyacetyl]-N-[[4-[imino[(
3-pyridinylmethoxy)amino]methyl]phenyl]methyl]-, (2S)-.
Check Digit Verification of cas no
The CAS Registry Mumber 433938-51-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,3,9,3 and 8 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 433938-51:
(8*4)+(7*3)+(6*3)+(5*9)+(4*3)+(3*8)+(2*5)+(1*1)=163
163 % 10 = 3
So 433938-51-3 is a valid CAS Registry Number.
433938-51-3Relevant academic research and scientific papers
Mandelic acid derivatives and their use as throbin inhibitors
-
Page/Page column 20, (2008/06/13)
There is provided a compound of formula I wherein Ra, R1, R2, Y and R3 have meanings given in the description and pharmaceutically acceptable derivatives (including prodrugs) thereof, which compounds and derivatives are useful as, or are useful as prodrugs of, competitive inhibitors of trypsin-like proteases, such as thrombin, and thus, in particular, in the treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants.
PHARMACEUTICAL COMBINATION
-
Page 53-55, (2010/02/04)
There is provided a combination product comprising: (1) a compound of claim 1 in WO 02/44145 or a compound of claim 20 in WO 02/44145 (or derivative thereof)or a pharmaceutically-acceptable derivative thereof; and (1) a compound as defined in claim 1 of WO 01/28992 or (2) a compound of Claim 34 of WO 01/28992 or (3) Compound A or B or C or D (or pharmaceutically-acceptable salts thereof) for use in treating arrhythmia or a coagulation controlled complication thereof.
